Digital Health

  • Samsung Health AI Models Analyze Wearable Biosignal Data

    Samsung Research America is advancing digital health with two AI foundation models, xMAE and HiMAE, for smartwatches. These models extract deep insights from biosignals, focusing on heart activity, sleep, and exertion. xMAE links PPG and ECG data for cardiovascular analysis, while HiMAE analyzes wearable data across multiple time scales. These innovations aim to provide efficient, precise, and continuous health insights, supporting Samsung’s “Connected Care” vision for personalized, preventive healthcare.

    2026年8月14日
  • Kyivstar Acquires Tabletki.ua to Bolster Digital Health Services in Ukraine

    Kyivstar, a VEON company, is expanding its digital health services by acquiring Tabletki.ua, an online pharmacy aggregator. This move strengthens Kyivstar’s position in Ukraine’s growing digital health market, aiming to provide subscribers with a more integrated experience for accessing medications and health products. The acquisition diversifies Kyivstar’s revenue and leverages technology to enhance its offerings, potentially including personalized health content and new applications.

    Markets 2026年2月17日
  • Amazon Unveils AI Healthcare Assistant for One Medical Subscribers

    Amazon’s One Medical has launched Health AI, an AI-powered assistant for its primary care members. This tool offers personalized health advice, medication management, and appointment scheduling by integrating with patient medical records. It aims to provide a more tailored experience than general chatbots, distinguishing itself by accessing a blend of proprietary data, expert medical knowledge, and public information. This move intensifies competition in the digital health market, with companies like OpenAI and Anthropic also introducing similar AI solutions. Amazon emphasizes that Health AI is a supplementary tool and not a replacement for professional medical care.

    2026年2月13日
  • RadNet Announces Record Q2 Results & Raised 2025 Guidance

    RadNet (RDNT) reported record Q2 2025 results, with revenue up 8.4% to $498.2M and Adjusted EBITDA increasing 12.3% to $81.2M. Digital Health segment revenue rose 30.9% to $20.7M. Advanced imaging volumes grew strongly: MRI +9.0%, CT +8.1%, PET/CT +22.4%. Adjusted EPS nearly doubled to $0.31. RadNet raised its 2025 revenue guidance to $1.85-1.90 billion and Adjusted EBITDA to $271-279 million. The company holds $833.2M cash and a low 0.96x leverage ratio.

    2025年8月10日
  • Hydreight Announces 34% Year-Over-Year Q1 Revenue Growth, Enhanced Bottom Line, and Strong Performance Across All Verticals

    Hydreight Technologies reported strong Q1 2025 results, with a 34% year-over-year revenue increase to $6.53 million. GAAP revenue reached $4.54 million, and gross margin and adjusted EBITDA improved. The company achieved net profitability, ending the quarter with $6.04 million in cash. New nurse signups and pharmacy orders grew significantly. Driven by its strategic initiatives, Hydreight is focused on expansion and profitability within the digital health sector.

    2025年5月30日